Novel approaches to the management of bone metastases in patients with breast cancer

被引：34

作者：

Hortobagyi, GN ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34066

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：134 / 144

页数：11

共 99 条

[1]

[Anonymous], ANN ONCOLOGY S7

[2] Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates:: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs [J].

Benford, HL ;

Frith, JC ;

Auriola, S ;

Mönkkönen, J ;

Rogers, MJ .

MOLECULAR PHARMACOLOGY, 1999, 56 (01) :131-140

[3]

Berenson James R., 1998, Current Opinion in Oncology, V10, P566, DOI 10.1097/00001622-199811000-00015

[4]

Berenson JR, 2001, SEMIN ONCOL, V28, P25

[5]

Berenson JR, 2001, CLIN CANCER RES, V7, P478

[6]

Blamey R, 1999, EUR J SURG ONCOL, V25, P3

[7] Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review [J].

Bloomfield, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1218-1225

[8] TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH THE BISPHOSPHONATE PAMIDRONATE - DOSE-RESPONSE RELATIONSHIP AND INFLUENCE OF TUMOR TYPE [J].

BODY, JJ ;

DUMON, JC .

ANNALS OF ONCOLOGY, 1994, 5 (04) :359-363

[9] A dose-finding study of zoledronate in hypercalcemic cancer patients [J].

Body, JJ ;

Lortholary, A ;

Romieu, G ;

Vigneron, AM ;

Ford, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561

[10] Current use of bisphosphonates in oncology [J].

Body, JJ ;

Bartl, R ;

Burckhardt, P ;

Delmas, PD ;

Diel, IJ ;

Fleisch, H ;

Kanis, JA ;

Kyle, RA ;

Mundy, GR ;

Paterson, AHG ;

Rubens, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3890-3899

← 1 2 3 4 5 6 7 8 9 10 →